US Patent

US10195168 — Gamma-hydroxybutyrate compositions and their uses for the treatment of disorders

Formulation · Assigned to Jazz Pharmaceuticals Ireland Ltd · Expires 2033-01-11 · 7y remaining

Vulnerability score 42/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects pharmaceutical compositions and formulations of mixed salts of gamma-hydroxybutyrate for treating various sleep disorders.

USPTO Abstract

Provided herein are pharmaceutical compositions and formulations comprising mixed salts of gamma-hydroxybutyrate (GHB). Also provided herein are methods of making the pharmaceutical compositions and formulations, and methods of their use for the treatment of sleep disorders such as apnea, sleep time disturbances, narcolepsy, cataplexy, sleep paralysis, hypnagogic hallucination, sleep arousal, insomnia, and nocturnal myoclonus.

Drugs covered by this patent

Patent Metadata

Patent number
US10195168
Jurisdiction
US
Classification
Formulation
Expires
2033-01-11
Drug substance claim
No
Drug product claim
Yes
Assignee
Jazz Pharmaceuticals Ireland Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.